Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2024-08-22 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
北京市中伦（广州）律师事务所关于广东驱动力生物科技集团股份有限公司 2024 年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality of the convening and procedures of the 2024 first extraordinary general meeting (临时股东大会) of Guangdong Drive Biotechnology Group Co., Ltd. It details the convening procedures, attendance, voting methods, and results of the shareholder meeting. The document does not contain financial statements or performance data, nor is it a report of financial results or management discussion. It is not an announcement of a report but a legal opinion on the shareholder meeting's legality and voting results. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholder meeting.
2024-08-22 Chinese
未来三年（2024-2026 年）股东分红回报规划
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement regarding the company's profit distribution policy and shareholder dividend return plan for the years 2024-2026. It references regulatory guidelines from the China Securities Regulatory Commission and outlines principles, conditions, and procedures for dividends and profit distribution. The document is not a financial report, earnings release, or management discussion but rather a formal policy announcement related to dividends and shareholder returns. It does not contain financial statements or earnings data but focuses on the dividend policy framework and governance around profit distribution. Given the content and focus on dividend policy and shareholder returns, this fits best under the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related shareholder details. The document is 2580 characters long, which is consistent with a detailed announcement rather than a full report.
2024-08-07 Chinese
第三届监事会第十五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Guangdong Driving Force Biotechnology Group Co., Ltd. It details the meeting date, attendance, agenda items, and voting results. The content includes approval of proposals related to shareholder dividend plans and insurance for directors and senior management. It references further detailed disclosures on the Beijing Stock Exchange information platform but does not contain financial statements or detailed financial data itself. The document is a formal announcement of meeting resolutions rather than a full report or financial filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-08-07 Chinese
关于召开2024年第一次临时股东大会通知公告（提供网络投票）
Regulatory Filings Classification · 95% confidence The document is a notice announcing the convening of the 2024 first extraordinary general meeting of shareholders (临时股东大会通知公告). It includes details about the meeting date, voting methods, attendees, agenda items, registration methods, and contact information. It does not contain any financial statements, audit results, or detailed financial data. The document is relatively short (2400 characters) and serves as an announcement for the meeting rather than the meeting materials or results. Therefore, it fits the category of a regulatory announcement related to shareholder meetings but not the actual meeting materials or voting results. Given the options, the best fit is Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-08-07 Chinese
第三届董事会第十七次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of resolutions passed at the 17th meeting of the third board of directors of Guangdong Driving Force Biotechnology Group Co., Ltd. It details the meeting's attendance, agenda items, voting results, and references to related announcements on the stock exchange platform. The content focuses on board meeting decisions, including proposals for shareholder dividends, convening a shareholders' meeting, and purchasing director and officer liability insurance. There is no financial data, earnings information, or detailed report content. The document is clearly a Board/Management Information announcement about board meeting resolutions and decisions.
2024-08-07 Chinese
关于购买公司和董监高责任险的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's decision to purchase liability insurance for the company and its directors, supervisors, and senior management. It includes details about the insurance plan, the approval process by the board and supervisory committee, and the submission of the proposal to the shareholders' meeting for approval. There are no financial statements, earnings data, or detailed financial analysis present. The document is a formal announcement of a corporate governance-related insurance purchase and the related board and supervisory approvals. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it contains substantive content about the insurance plan and approvals. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-08-07 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.